CAS RN 755037-03-7
Regorafenib, TRC
CAS: 755037-03-7 Fórmula molecular: C21 H15 Cl F4 N4 O3 Peso molecular (g/mol): 482.82 Sinónimo: 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-,4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide,4-[4-[N'-(4-Chloro-3-trifluoromethylphenyl)ureido]-3-fluorophenoxy]pyridine-2-carboxylic acid methylamide,BAY 73-4506,Regorafenib,Stivarga Nombre IUPAC: 4-[4-[[4-cloro-3-(trifluorometil)fenil]carbamoilamino]-3-fluorofenoxi]-N-metilpiridina-2-carboxamida SMILES: CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1
Regorafenib, MedChemExpress
MedChemExpress Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity.